Schoolcraft Capital’s Standard BioTools LAB Stock Holding History

Schoolcraft Capital’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-74,224	Closed	-$80.2K	–	69
2025 Q1	$80.2K	Hold	74,224	–	–	0.02%	74
2024 Q4	$130K	Hold	74,224	–	–	0.03%	68
2024 Q3	$143K	Hold	74,224	–	–	0.03%	68
2024 Q2	$131K	Hold	74,224	–	–	0.03%	66
2024 Q1	$201K	Buy	+74,224	New	+$179K	0.05%	65

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Schoolcraft Capital's LAB Position: Q2 2025 in Review

Schoolcraft Capital sold out of Standard BioTools (LAB) in Q2 2025, closing a stake of 74,224 shares — an estimated $80.2K sold.

Schoolcraft Capital first reported a position in LAB in Q1 2024 and held it in 5 quarters. The position peaked at $201K in Q1 2024. 160 funds tracked by Wall St. Rank hold LAB as of Q2 2025.

Schoolcraft Capital reported no remaining Standard BioTools position as of Q2 2025 after selling out during the quarter.
Schoolcraft Capital sold 74,224 Standard BioTools shares in Q2 2025, an estimated $80.2K.
Schoolcraft Capital first reported a position in Standard BioTools in Q1 2024 and held it in 5 quarters.
Schoolcraft Capital's Standard BioTools position peaked at $201K in Q1 2024.
160 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2025.

Based on Schoolcraft Capital's 13F filing for Q2 2025, filed 31 Jul 2025.